Belialov F. Treatment of heart disease in terms of comorbidity. Irkutsk: PIO IGMAPO 2014,; p. 308.
Roberts KC, Rao DP, Bennett TL, Loukine L, Jayaraman GC. Prevalence and patterns of chronic disease multimorbidity and associated determinants in Canada Health Promot Chronic Dis Prev Can 2015; 35(6): 87-94.
Nikolaev YuA, Sevostyanova EV, Mitrofanov IM, Polyakov VYa, Dolgova NA. Features of polymorbidity in patients of a therapeutic clinic of the cardiological and gastroenterological profile. Therapeutic archive 2016; 1: 40-5.
Dolgova NA, Shkurupy VA, Yakimova AV, Dobrovolskaya NP. Deforming dorsopathy in patients with a combination of arterial hypertension, dyslipidemia and obesity: Possible solutions of the problem. Bull Russ Acad Med Sci 2014; 34(2): 61-5.
Nikolaev YuA, Mitrofanov IM, Pospelova TI, Dolgova NA, Polyakov VYa. Features of polymorbidity in the modern clinic of internal diseases. Bulletin of the SB RAMS 2014; 34(2): 44-9.
Chazova IE, Oschepkova EV. Experience in dealing with cardiovascular diseases in Russia. Analytical Vestnik 2015; 44(597): 4-8.
Oganov RG. Arterial hypertension. Moscow: GEOTAR-Media 2008.
Komarov FI, Rapoport SI. Guide to gastroenterology M. Medical Information Agency 2010.
Hassan K, Bhalla V, Regal ME. A-Kader HH. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol 2014; 20: 12082–101. J Gastroenterol 2014; 20(37): 13306-24.
Ivashkin VT, Mayevskaya MV, Pavlov ChS, et al. Clinical recommendations on the diagnosis and treatment of non-alcoholic fatty liver disease of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association. Rus J Gastroenterol, hepatol. Coloproctol 2016; 26(2): 24-42.
Polyakov VYa, Nikolaev YuA, Obukhov IV, Gevorgyan MM. Features of clinical and functional parameters in patients with arterial hypertension combined with diseases of the hepatobiliary system in the conditions of the North. Bulletin of new medical technologies 2013; 2: 395-399..
Vya P, Nikolaev YuA, Pegova SV, et al. Features of changes of the carotid and vertebral arteries in patients with arterial hypertension associated with the pathology of the hepatobiliary system. Clin Med (Northfield Ill) 2016; 1: 39-42.
Sevostyanova EV, Polyakov VYA, Nikolaev YUA, Mitrofanov IM. Risk factors for hypertension in patients with non-alcoholic fatty liver disease clinical medicine 2018; 6: 395-399..
Mitrofanov IM, Nikolaev YuA, Dolgova NA, Pospelova TI. Regional features of polymorbidity in the modern clinic of internal diseases. Clin Med (Northfield Ill) 2013; 6: 26-9.
Sevostyanova EV, Nikolaev YuA, Mitrofanov IM, Polyakov VYa, Dolgova NA. The role of risk factors for chronic non-communicable diseases in the development of polymorbid pathology. Clin Med (Northfield Ill) 2017; 95(8): 735-41.
Ermakova MA, Aftanas LI, Shpagina LA. Characteristics of psychophysiological markers of stress in patients with arterial hypertension, depending on the degree of occupational risk. Bulletin SB RAMS 2014; 4: 42-7.
Balukova EV. Non-alcoholic fatty liver disease and the risk of cardiovascular events. Russ Med J 2013; 13: 737-40.
Zvenigorodskaya LA, Samsonova NG, Efremov LI, Cherkashova EA, Lazebnik LB. Gastrointestinal aspects of atherosclerosis. Exp Cllin Gastroenterol 2011; 2: 31-6.
Vorobyova EN, Schumacher GI, Khoreva MA, Osipova IV. Endothelial dysfunction is a key element in the pathogenesis of atherosclerosis. Russ J Cardiol 2010; 2(82): 84-91.
Aryev A, Ovsyannikova NA, Aryeva GT, et al. Geriatric polymorbidity. Prac Oncol 2015; 16(3): 83-9.
Efremov LI, Komisarenko IA. Metabolic continuum and polymorbidity in geriatrics. Exp Cllin Gastroenterol 2014; 106(6): 4-7.
Tsanava IA, Sharonova LA, Verbovoy AF. Metabolic syndrome and cardiovascular diseases. RMJ. Med Rev 2017; 11: 785-9.
Korneeva ON, Drapkina OM, Buyever AO, Ivashkin VT. Non-alcoholic fatty liver disease as a manifestation of the metabolic syndrome. Clin Perspec Gastroenterol Hepatol 2005; 4: 24.
Nikolenko LA, Goloshchapova ZA, Golovneva ES, Nikolenko ES. Risk factors for cardiovascular diseases in postmenopausal women and prophylactic methods for reducing them (literature review). RMJ 2016; 5: 328-30.
Smirnova AV, Suhorukov VN, Karagodin VP, Orehov AN. Epigenetic factors in atherogenesis: miRNA. Biomeditsinskaya Chem 2016; 62(2): 134-40.